-
CSR Summary Not yet available
-
NCT02437162
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameUstekinumabProduct NameSTELARA®Therapeutic AreaMuscle, Bone, and Cartilage DiseasesEnrollment347% Female15%% White72.8%
Product ClassmAB anti-IL12 and anti-IL23Sponsor Protocol NumberCNTO1275AKS3001Data PartnerJohnson & JohnsonCondition StudiedAxial SpondyloarthritisMean/Median Age (Years)39
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available